Exelixis stock falls as FDA extends zanzalintinib review

The Atlantic fixed its business. Then AI came for media.

Courtesy of The Atlantic; BI Nicholas Thompson, the CEO of The Atlantic magazine, put together a deal with OpenAI in 202…

Helus Pharma at Cantor conference: phase III readout in focus

FingerMotion reports $5.1M cash, cuts monthly burn by 30%